Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
- 04 décembre 2024 - 1 mn de lecture
The purpose of this study is to investigate if early administration (i.e. within 12 weeks after stroke) of Dysport® 500 U injections may delay the appearance or the progression of upper limb symptomatic spasticity.
04 décembre 2024
1 mn de lecture
A Long-Term Study of Elafibranor in Adult Participants with Primary Biliary Cholangitis
04 décembre 2024
1 mn de lecture
A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants with Primary Sclerosing Cholangitis.
04 décembre 2024
1 mn de lecture
A Study to Evaluate the Effect of Food on the Level of Circulating Elafibranor in Healthy Participants after Intake of a Single Tablet
04 décembre 2024
1 mn de lecture
Study to Compare the Level of Elafibranor in Blood after Repeat Administration in Japanese and non-Asian Healthy Participants
04 décembre 2024
1 mn de lecture
A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ?14 Years With Fibrodysplasia Ossificans Progressiva...
04 décembre 2024
1 mn de lecture
Effects of maintenance cabozantinib+BSC versus BSC in children and AYA with osteosarcoma.
04 décembre 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of episodic migraine in adults
04 décembre 2024
2 mn de lecture
A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults
04 décembre 2024
1 mn de lecture
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
04 décembre 2024
2 mn de lecture